Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.

Medicine - 1 May 2018

Russano de Paiva Silva Geisilene, Tournier Emilie, Sarian Luis Otávio, Bulai-Livideanu Cristina, Delsol Georges, Lamant Laurence, Vassallo José, Brousset Pierre, Laurent Camille

Abstract excerpt

Mastocytosis is a rare disease characterized by clonal neoplastic proliferation of mast cells (MCs). It ranges from skin lesions as cutaneous mastocytosis (CM) which may spontaneously regress to highly aggressive neoplasms with multiorgan involvement corresponding to some aggressive systemic mastocytosis (ASM), mast cell leukemia (MCL), and/or mast cell sarcoma (MCS).There is increasing evidence of CD30...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Diagnosis, Differential

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Ki-1 Antigen

Share to Mast Cells

Share to Mastocytosis

Share to Proto-Oncogene Proteins c-kit

Source

Open in PubMed Open full text

Identifiers

PMID: 29794740
DOI: 10.1097/MD.0000000000010642
PMCID: PMC6392733

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of CD30 immunostaining in neoplastic mast cells: A retrospective immunohistochemical study.PMID 29794740Read ↗

Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis.Semantic proximity Read ↗

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.Semantic proximity Read ↗

Diagnostic criteria and classification of mastocytosis: a consensus proposal.Semantic proximity Read ↗

Mastocytosis and related disorders.Semantic proximity Read ↗

Bone Marrow Expression of Mast Cell Disorders.Semantic proximity Read ↗

Cutaneous Lesions of Mastocytosis: Mast Cell Count, Morphology, and Immunomolecular Phenotype.Semantic proximity Read ↗

Primary Cutaneous CD30 positive Lymphoproliferative Disorders—Current Therapeutic Approach with Focus on Brentuximab VedotinSemantic proximity Read ↗

Cutaneous mastocytosis: A dermatological perspective.Semantic proximity Read ↗

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.Semantic proximity Read ↗

Pathology of extramedullary mastocytosis.Semantic proximity Read ↗

Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells.Semantic proximity Read ↗

Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.